TGTX
TG THERAPEUTICS INC
Latest close $49.88 as of Aug 5, 2026
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro.
Compare plans.
Beneficial ownership filing history
Showing 3 of 6 parsed filing(s) · 3 older require more history access| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Vanguard Group CIK0000102909 | Mar 13, 2026 observed Mar 27, 2026 filed · 14d Schedule 13G amendment | Earliest Schedule 13G amendment found | 11 | 12.00% | $27.96 | $31.75 | $49.88 |
| State Street CIK0000093751 | Sep 30, 2025 observed Nov 10, 2025 filed · 41d Initial Schedule 13G | Initial Schedule 13G | 8.1M +666.7K | 12.00% 0.00 pts | $36.13 | $30.30 | $49.88 |
| State Street CIK0000093751 | Mar 31, 2025 observed May 13, 2025 filed · 43d Initial Schedule 13G | Initial Schedule 13G | 7.4M | 12.00% | $49.88 |